It has also been well documented that the inhibition of HO-1 is capable of restoring the chemosensitivity of resistant cells in multiple cancer types, including ovarian cancer [169], acute myeloid leukemia [170], and melanoma [154]. This evidence concerns the gene HMOX1 and ovarian cancer.